Plexus Corp. (NASDAQ:PLXS – Get Free Report) CFO Patrick John Jermain sold 4,328 shares of the company’s stock in a transaction that occurred on Thursday, May 15th. The shares were sold at an average price of $132.29, for a total value of $572,551.12. Following the completion of the sale, the chief financial officer now owns 25,637 shares in the company, valued at $3,391,518.73. The trade was a 14.44% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Plexus Trading Down 1.0%
PLXS traded down $1.33 during trading on Monday, hitting $132.95. The company’s stock had a trading volume of 100,156 shares, compared to its average volume of 168,630. The firm has a market capitalization of $3.60 billion, a P/E ratio of 30.85 and a beta of 0.80. Plexus Corp. has a twelve month low of $100.96 and a twelve month high of $172.89. The company has a quick ratio of 0.70, a current ratio of 1.53 and a debt-to-equity ratio of 0.07. The stock’s fifty day moving average price is $124.90 and its 200-day moving average price is $143.02.
Plexus (NASDAQ:PLXS – Get Free Report) last issued its earnings results on Wednesday, April 23rd. The technology company reported $1.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.12. The business had revenue of $980.17 million for the quarter, compared to analyst estimates of $980.07 million. Plexus had a net margin of 3.03% and a return on equity of 10.36%. Plexus’s revenue was up 1.4% on a year-over-year basis. During the same period in the prior year, the firm earned $0.94 earnings per share. Analysts anticipate that Plexus Corp. will post 5.9 EPS for the current year.
Institutional Trading of Plexus
Analyst Ratings Changes
PLXS has been the topic of a number of recent analyst reports. Benchmark restated a “buy” rating and issued a $160.00 price target on shares of Plexus in a research report on Friday. Stifel Nicolaus set a $145.00 target price on shares of Plexus in a report on Thursday, April 24th. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $162.00 price target (down previously from $172.00) on shares of Plexus in a research report on Friday, April 25th. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat, Plexus has a consensus rating of “Moderate Buy” and an average price target of $155.67.
Check Out Our Latest Stock Report on Plexus
Plexus Company Profile
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
See Also
- Five stocks we like better than Plexus
- Stock Splits, Do They Really Impact Investors?
- UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?
- 3 Fintech Stocks With Good 2021 Prospects
- What Ray Dalio’s Latest Moves Tell Investors
- Top Biotech Stocks: Exploring Innovation Opportunities
- Amazon: Why May Is the Last Month to Get the Stock at a Discount
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.